Rubella Mass Campaigns
- S. Reef
- … show all 1 hide
Purchase on Springer.com
$29.95 / €24.95 / £19.95*
* Final gross prices may vary according to local VAT.
The availability of vaccines that contain both measles and rubella components allows for the elimination of both diseases. Although routine infant vaccination with rubella vaccine has had profound effects on the incidence of both acquired and congenital rubella, mass vaccination rapidly stops circulation of the virus and prevents paradoxical increases in susceptibility of women that might result from decreased exposure in childhood. Whereas routine rubella vaccination has eliminated the infection from many developed countries, mass vaccination has rapidly accomplished the same goal in Latin America and the Caribbean, and is being applied in other developing country areas.
- Gregg NM (1941) Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust 3:35–46
- Weller TH, Neva FA (1962) Propagation in tissue culture of cytopathic agents from patients with rubella-like illness. Proc Soc Exp Bio Med 111:215–225
- Parkman PD, Beuscher EL, Artenstein MS (1962) Recover of rubella virus from army recruits. Proc Soc Exp Bio Med 111:225–230
- Cooper LZ (1975) Congenital rubella in the United States. In: Krugman S, Gershon A (eds). Symposium on infections of the fetus and newborn infant. Alan R. Liss, New York
- Centers for Disease Control and Prevention (1969) Prelicensing statement on rubella virus vaccine: Recommendation of the Public Health Service Advisory committee on Immunization Practices. MMWR 18
- Tobin JO, Sheppard S, Smithells RW, Milton A, Noach N, Reid D (1985) Rubella in the United Kingdom, 1970–1983. Rev Infect Dis 7:S47–S52
- Irons B, Lewis MJ, Dahl-Regis M, Castillio-Soloranzo Carrasco P, deQuadro C (2000) Strategies to eradicate rubella in the English-speaking Caribbean. Am J Public Health 90:1545–1549 CrossRef
- Vyse AJ, Gay NJ, White JM, et al. (2002) Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy. Epidemiol Rev 24(2):125–136. CrossRef
- Castillo-Solorzano C, Carrasco P, Tambini G, et al. (2003) New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas. J Infect Dis 187Suppl 1:S146–152. CrossRef
- de Quadros CA, Izurieta H, Venczel L, Carrasco P (2003) Measles eradication in the Americas: progress to date. J Infect Dis 189Suppl 1:S227–235.
- Hinman AR, Hersh BS, deQuadros C (1998) Rationale use of Rubella vaccine for the prevention of congenital rubella syndrome in the Americas. Rev Panam Salud Publica 4:156–160
- World Health Organization (2000) Rubella vaccine: WHO position paper. Wky Epidemiol Rec 75(20):161–166.
- WHO Weekly Epidemiologic Record (2005) Progress towards elimination of measles and prevention of congenital rubella infection in the WHO European Region 1990–2004. WHO WER 80:66–71
- Rubella Mass Campaigns
- Book Title
- Mass Vaccination: Global Aspects — Progress and Obstacles
- pp 221-229
- Print ISBN
- Online ISBN
- Series Title
- Current Topics in Microbiology and Immunology
- Series Volume
- Series ISSN
- Springer Berlin Heidelberg
- Copyright Holder
- Springer-Verlag Berlin Heidelberg
- Additional Links
- Industry Sectors
- eBook Packages
To view the rest of this content please follow the download PDF link above.